A Study to Evaluate the Efficacy and Safety of Pioglitazone 15mg or 30mg Add-on in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin
Condition: Type2 Diabetes Interventions: Drug: Metformin≥1000mg + Dapagliflozin 10mg; Drug: Pioglitazone 15mg; Drug: Pioglitazone 30 mg; Drug: Pioglitazone 15mg Placebo; Drug: Pioglitazone 30mg Placebo Sponsor: Boryung Pharmaceutical Co., Ltd Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Actos | Dapagliflozin | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Fortamet | Forxiga | Metformin | Research | Study